Ziopharm Oncology, Inc. – Trademark Portfolio
Entity Type: 03
Ziopharm Oncology, Inc. holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 18 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include HUNTR, ZIOPHARM, and ALAUNOS THERAPEUTICS. The owner is based in Boston, MA.
Navy Yard Plaza One First Avenue
Parris Building #34
Boston, MA 02129
Showing of trademarks Trademarks
Trademark Classifications
Ziopharm Oncology, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Ziopharm Oncology, Inc. have?
Ziopharm Oncology, Inc. has 22 U.S. trademarks filed with the USPTO. Of these, 7 registered, 12 abandoned, 3 cancelled.
What trademark classes does Ziopharm Oncology, Inc. file in?
Ziopharm Oncology, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Ziopharm Oncology, Inc.'s most well-known trademarks?
Ziopharm Oncology, Inc.'s registered trademark portfolio includes well-known marks such as HUNTR, ZIOPHARM, and ALAUNOS THERAPEUTICS. These are among 7 currently registered trademarks in the portfolio.
What is Ziopharm Oncology, Inc.'s trademark registration success rate?
Ziopharm Oncology, Inc. has a 32% trademark registration rate, with 7 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.